ArticleAnnals of hematology2025

Safety and efficacy of venetoclax-azacitidine combined with low-dose Idarubicin and cytarabine regimens for the treatment of newly diagnosed acute myeloid leukemia patients compared to the standard chemotherapy: a propensity score-matched real-world single-center experience.

Xiao-Tong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.